Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Neonatal Intensive Care Market by Product (Warmers, Incubators, Monitoring Devices, Respiratory Devices, Phototherapy Equipment, Others), by Application (Neonatal Hypothermia & Low Birth Weight, Jaundice, Others), by End User (Hospitals, Maternity Hospitals, Neonatal & Pediatric Hospital): Global Opportunity Analysis and Industry Forecast, 2021-2031

A17086

Pages: 363

Charts: 69

Tables: 195

Neonatal Intensive Care Market Research, 2031

The global neonatal intensive care market was valued at $2.0 billion in 2021 and is projected to reach $4.4 billion by 2031, growing at a CAGR of 8.2% from 2022 to 2031. A neonatal intensive care unit (NICU), also known as an intensive care nursery (ICN), is an intensive care unit (ICU) specializing in the care of ill or premature newborn infants. Neonatal refers to the first 28 days of life. The neonatal intensive care unit (NICU) is equipped with various advanced instruments such as infant ventilators, neonatal incubators and infant warmers.

[COVIDIMPACTSTATEMENT]

Get more information on this report : Request Sample Pages

The increase in the prevalence of neonatal hypothermia and rise in incidences of low birth weight of infants drives the Neonatal Intensive Care Market growth. Neonatal hypothermia is the reduction in the body temperature of the newborn (less than 36.5°C). The neonatal intensive care unit (NICU) provides care for babies who are born prematurely (before 37 weeks gestation), with a medical condition that needs treatment, or at low birth weight. In addition, an increase in the prevalence of preterm birth rate drives the growth of the market. The key factors such as the medical condition of the mother, diabetes, drug consumption, alcoholism, and multiple pregnancies contribute to the increase in the prevalence of preterm birth.

Furthermore, the increasing risk of COVID-19 infection and other respiratory diseases in newborn babies drives the growth of the market. babies under age 1 might be at higher risk of severe illness with COVID-19 than older children. According to the Centers for Disease Control and Prevention (CDC) surveillance report, from March 29–October 14, 2020, 923 newborns were born to women with COVID-19; among these newborns, 2.6% tested positive for SARS-CoV-2 after birth. Thus, the prevalence of respiratory diseases and the growing risk of COVID-19 infection propels the demand of neonatal incubators and infant ventilators.

Moreover, an increase in R&D activity for advancements in neonatal intensive care, and product approvals contribute to the growth of the market. For instance, in May 2022, Medtronic plc, a global leader in healthcare technology, received the U.S. Food and Drug Administration (FDA) granting 510(k) clearance for the Nellcor OxySoft SpO2 sensor.

The growing interest of manufacturers & developers in the development of neonatal intensive care and the latest product launch drives the growth of the Neonatal Intensive Care Industry. For instance, in November 2021, Medtronic plc, a global medical technology company, announced the U.S. commercial launch of the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine following the U.S. Food and Drug Administration's (FDA) marketing authorization. In addition, combined manufacturers' efforts for developing footprints in emerging market contributes to the growth of Neonatal Intensive Care Market size.

In addition, the increased need for the installation of NICU units and a rise in awareness among individuals regarding neonatal care is expected to boost the growth of the Neonatal Intensive Care Market size. Furthermore, growing concern for neonatal care contributes to the growth of the market.

The neonatal intensive care market is segmented into Product, Application, End User, and Region.

By product, the segment market is divided into warmers, incubators, monitoring devices, respiratory devices, phototherapy equipment, and others. The incubators are divided into hybrid incubators, normal incubators, and transport incubators. Depending on the application classified into neonatal hypothermia & low birth weight, jaundice and others. Based on the end-user market is categorized into hospitals, maternity hospitals, and neonatal & pediatric hospitals.

By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).

Depending on the product, the respiratory devices segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to advancements in neonatal intensive care and the increasing prevalence of respiratory diseases. However, the incubators segment is expected to witness considerable growth during the forecast period, due to an increase in the installation of incubators in neonatal intensive care units (NICU) and the latest product launch in the market.

[PRODUCTGRAPH]

Based on application, the neonatal hypothermia & low birth weight segment dominated the market in 2021, and this trend is expected to continue during the Neonatal Intensive Care Market forecast period, owing to the increasing prevalence of neonatal hypothermia and the rise in the incidence of preterm birth. However, the jaundice segment is expected to witness considerable growth during the forecast period, due to an increase in the prevalence of neonatal jaundice and premature childbirth.

[APPLICATIONGRAPH]

By end user, the neonatal & pediatric hospital segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to a rise in the number of neonatal & pediatric hospitals and an increase in demand of advanced treatment. However, the hospital segment is expected to witness considerable growth during the forecast period, due to an increase in the number of hospitals and a rise in healthcare expenditures.

[ENDUSERGRAPH]

Depending on the region, Asia-Pacific garnered the major share in the Neonatal Intensive Care Market share in 2021 and is expected to dominate the global market during the forecast period, increase in product launches in the region, a rise in healthcare expenditures, and the presence of high population base. However, North America is expected to register significant growth, owing to the presence of well-established healthcare infrastructure, development in healthcare infrastructure, and the presence of key players.

[REGIONGRAPH]

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neonatal intensive care market analysis from 2021 to 2031 to identify the prevailing neonatal intensive care market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • An in-depth analysis of the neonatal intensive care market segmentation assists to determine the prevailing Neonatal Intensive Care Market opportunity.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global neonatal intensive care market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Product
    • Warmers
    • Incubators
      • Type
        • Hybrid Incubator
        • Normal Incubator
        • Transport Incubator
    • Monitoring Devices
    • Respiratory Devices
    • Phototherapy Equipment
    • Others
  • By Application
    • Neonatal Hypothermia & Low Birth Weight
    • Jaundice
    • Others
  • By End User
    • Hospitals
    • Maternity Hospitals
    • Neonatal & Pediatric Hospital
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • Italy
      • Spain
      • Rest of Europe
      • Germany
      • France
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Koninklijke Philips N.V
  • Vygon (UK) Ltd
  • Medtronic PLC
  • Terumo Corporation
  • GE Company
  • Zhengzhou Dison Instrument And Meter Co., Ltd
  • Ningbo David Medical Device Co., Ltd.
  • Masimo Corporation
  • Medicor Elektronika
  • Atom Medica
  • AngioDynamics
  • Mediprema Group
  • Siemens Healthcare GmbH
  • Drägerwerk AG & Co. KGaA
  • Phoenix Medical Systems Pvt Ltd.
  • Fanem Medical Devices
  • 3M Company
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: NEONATAL INTENSIVE CARE MARKET, BY PRODUCT

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Warmers

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Incubators

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

      • 4.3.4 Incubators Neonatal Intensive Care Market by Type

        • 4.3.4.1 Hybrid Incubator Market size and forecast, by region
        • 4.3.4.2 Normal Incubator Market size and forecast, by region
        • 4.3.4.3 Transport Incubator Market size and forecast, by region
    • 4.4 Monitoring Devices

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Respiratory Devices

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

    • 4.6 Phototherapy Equipment

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market analysis by country

    • 4.7 Others

      • 4.7.1 Key market trends, growth factors and opportunities

      • 4.7.2 Market size and forecast, by region

      • 4.7.3 Market analysis by country

  • CHAPTER 5: NEONATAL INTENSIVE CARE MARKET, BY APPLICATION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Neonatal Hypothermia & Low Birth Weight

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Jaundice

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Others

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

  • CHAPTER 6: NEONATAL INTENSIVE CARE MARKET, BY END USER

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 Hospitals

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market analysis by country

    • 6.3 Maternity Hospitals

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market analysis by country

    • 6.4 Neonatal & Pediatric Hospital

      • 6.4.1 Key market trends, growth factors and opportunities

      • 6.4.2 Market size and forecast, by region

      • 6.4.3 Market analysis by country

  • CHAPTER 7: NEONATAL INTENSIVE CARE MARKET, BY REGION

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 North America

      • 7.2.1 Key trends and opportunities

      • 7.2.2 North America Market size and forecast, by Product

        • 7.2.2.1 North America Incubators Neonatal Intensive Care Market by Type
      • 7.2.3 North America Market size and forecast, by Application

      • 7.2.4 North America Market size and forecast, by End User

      • 7.2.5 North America Market size and forecast, by country

        • 7.2.5.1 U.S.
          • 7.2.5.1.1 Market size and forecast, by Product
          • 7.2.5.1.2 Market size and forecast, by Application
          • 7.2.5.1.3 Market size and forecast, by End User
        • 7.2.5.2 Canada
          • 7.2.5.2.1 Market size and forecast, by Product
          • 7.2.5.2.2 Market size and forecast, by Application
          • 7.2.5.2.3 Market size and forecast, by End User
        • 7.2.5.3 Mexico
          • 7.2.5.3.1 Market size and forecast, by Product
          • 7.2.5.3.2 Market size and forecast, by Application
          • 7.2.5.3.3 Market size and forecast, by End User
    • 7.3 Europe

      • 7.3.1 Key trends and opportunities

      • 7.3.2 Europe Market size and forecast, by Product

        • 7.3.2.1 Europe Incubators Neonatal Intensive Care Market by Type
      • 7.3.3 Europe Market size and forecast, by Application

      • 7.3.4 Europe Market size and forecast, by End User

      • 7.3.5 Europe Market size and forecast, by country

        • 7.3.5.1 Germany
          • 7.3.5.1.1 Market size and forecast, by Product
          • 7.3.5.1.2 Market size and forecast, by Application
          • 7.3.5.1.3 Market size and forecast, by End User
        • 7.3.5.2 France
          • 7.3.5.2.1 Market size and forecast, by Product
          • 7.3.5.2.2 Market size and forecast, by Application
          • 7.3.5.2.3 Market size and forecast, by End User
        • 7.3.5.3 UK
          • 7.3.5.3.1 Market size and forecast, by Product
          • 7.3.5.3.2 Market size and forecast, by Application
          • 7.3.5.3.3 Market size and forecast, by End User
        • 7.3.5.4 Italy
          • 7.3.5.4.1 Market size and forecast, by Product
          • 7.3.5.4.2 Market size and forecast, by Application
          • 7.3.5.4.3 Market size and forecast, by End User
        • 7.3.5.5 Spain
          • 7.3.5.5.1 Market size and forecast, by Product
          • 7.3.5.5.2 Market size and forecast, by Application
          • 7.3.5.5.3 Market size and forecast, by End User
        • 7.3.5.6 Rest of Europe
          • 7.3.5.6.1 Market size and forecast, by Product
          • 7.3.5.6.2 Market size and forecast, by Application
          • 7.3.5.6.3 Market size and forecast, by End User
    • 7.4 Asia-Pacific

      • 7.4.1 Key trends and opportunities

      • 7.4.2 Asia-Pacific Market size and forecast, by Product

        • 7.4.2.1 Asia-Pacific Incubators Neonatal Intensive Care Market by Type
      • 7.4.3 Asia-Pacific Market size and forecast, by Application

      • 7.4.4 Asia-Pacific Market size and forecast, by End User

      • 7.4.5 Asia-Pacific Market size and forecast, by country

        • 7.4.5.1 China
          • 7.4.5.1.1 Market size and forecast, by Product
          • 7.4.5.1.2 Market size and forecast, by Application
          • 7.4.5.1.3 Market size and forecast, by End User
        • 7.4.5.2 Japan
          • 7.4.5.2.1 Market size and forecast, by Product
          • 7.4.5.2.2 Market size and forecast, by Application
          • 7.4.5.2.3 Market size and forecast, by End User
        • 7.4.5.3 India
          • 7.4.5.3.1 Market size and forecast, by Product
          • 7.4.5.3.2 Market size and forecast, by Application
          • 7.4.5.3.3 Market size and forecast, by End User
        • 7.4.5.4 Australia
          • 7.4.5.4.1 Market size and forecast, by Product
          • 7.4.5.4.2 Market size and forecast, by Application
          • 7.4.5.4.3 Market size and forecast, by End User
        • 7.4.5.5 South Korea
          • 7.4.5.5.1 Market size and forecast, by Product
          • 7.4.5.5.2 Market size and forecast, by Application
          • 7.4.5.5.3 Market size and forecast, by End User
        • 7.4.5.6 Rest of Asia-Pacific
          • 7.4.5.6.1 Market size and forecast, by Product
          • 7.4.5.6.2 Market size and forecast, by Application
          • 7.4.5.6.3 Market size and forecast, by End User
    • 7.5 LAMEA

      • 7.5.1 Key trends and opportunities

      • 7.5.2 LAMEA Market size and forecast, by Product

        • 7.5.2.1 LAMEA Incubators Neonatal Intensive Care Market by Type
      • 7.5.3 LAMEA Market size and forecast, by Application

      • 7.5.4 LAMEA Market size and forecast, by End User

      • 7.5.5 LAMEA Market size and forecast, by country

        • 7.5.5.1 Brazil
          • 7.5.5.1.1 Market size and forecast, by Product
          • 7.5.5.1.2 Market size and forecast, by Application
          • 7.5.5.1.3 Market size and forecast, by End User
        • 7.5.5.2 Saudi Arabia
          • 7.5.5.2.1 Market size and forecast, by Product
          • 7.5.5.2.2 Market size and forecast, by Application
          • 7.5.5.2.3 Market size and forecast, by End User
        • 7.5.5.3 South Africa
          • 7.5.5.3.1 Market size and forecast, by Product
          • 7.5.5.3.2 Market size and forecast, by Application
          • 7.5.5.3.3 Market size and forecast, by End User
        • 7.5.5.4 Rest of LAMEA
          • 7.5.5.4.1 Market size and forecast, by Product
          • 7.5.5.4.2 Market size and forecast, by Application
          • 7.5.5.4.3 Market size and forecast, by End User
  • CHAPTER 8: COMPANY LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Key developments

  • CHAPTER 9: COMPANY PROFILES

    • 9.1 Drägerwerk AG & Co. KGaA

      • 9.1.1 Company overview

      • 9.1.2 Company snapshot

      • 9.1.3 Operating business segments

      • 9.1.4 Product portfolio

      • 9.1.5 Business performance

      • 9.1.6 Key strategic moves and developments

    • 9.2 GE Company

      • 9.2.1 Company overview

      • 9.2.2 Company snapshot

      • 9.2.3 Operating business segments

      • 9.2.4 Product portfolio

      • 9.2.5 Business performance

      • 9.2.6 Key strategic moves and developments

    • 9.3 Masimo Corporation

      • 9.3.1 Company overview

      • 9.3.2 Company snapshot

      • 9.3.3 Operating business segments

      • 9.3.4 Product portfolio

      • 9.3.5 Business performance

      • 9.3.6 Key strategic moves and developments

    • 9.4 3M Company

      • 9.4.1 Company overview

      • 9.4.2 Company snapshot

      • 9.4.3 Operating business segments

      • 9.4.4 Product portfolio

      • 9.4.5 Business performance

      • 9.4.6 Key strategic moves and developments

    • 9.5 Phoenix Medical Systems Pvt Ltd.

      • 9.5.1 Company overview

      • 9.5.2 Company snapshot

      • 9.5.3 Operating business segments

      • 9.5.4 Product portfolio

      • 9.5.5 Business performance

      • 9.5.6 Key strategic moves and developments

    • 9.6 Medtronic PLC

      • 9.6.1 Company overview

      • 9.6.2 Company snapshot

      • 9.6.3 Operating business segments

      • 9.6.4 Product portfolio

      • 9.6.5 Business performance

      • 9.6.6 Key strategic moves and developments

    • 9.7 Koninklijke Philips N.V

      • 9.7.1 Company overview

      • 9.7.2 Company snapshot

      • 9.7.3 Operating business segments

      • 9.7.4 Product portfolio

      • 9.7.5 Business performance

      • 9.7.6 Key strategic moves and developments

    • 9.8 Fanem Medical Devices

      • 9.8.1 Company overview

      • 9.8.2 Company snapshot

      • 9.8.3 Operating business segments

      • 9.8.4 Product portfolio

      • 9.8.5 Business performance

      • 9.8.6 Key strategic moves and developments

    • 9.9 Atom Medica

      • 9.9.1 Company overview

      • 9.9.2 Company snapshot

      • 9.9.3 Operating business segments

      • 9.9.4 Product portfolio

      • 9.9.5 Business performance

      • 9.9.6 Key strategic moves and developments

    • 9.10 Mediprema Group

      • 9.10.1 Company overview

      • 9.10.2 Company snapshot

      • 9.10.3 Operating business segments

      • 9.10.4 Product portfolio

      • 9.10.5 Business performance

      • 9.10.6 Key strategic moves and developments

    • 9.11 Siemens Healthcare GmbH

      • 9.11.1 Company overview

      • 9.11.2 Company snapshot

      • 9.11.3 Operating business segments

      • 9.11.4 Product portfolio

      • 9.11.5 Business performance

      • 9.11.6 Key strategic moves and developments

    • 9.12 Terumo Corporation

      • 9.12.1 Company overview

      • 9.12.2 Company snapshot

      • 9.12.3 Operating business segments

      • 9.12.4 Product portfolio

      • 9.12.5 Business performance

      • 9.12.6 Key strategic moves and developments

    • 9.13 Medicor Elektronika

      • 9.13.1 Company overview

      • 9.13.2 Company snapshot

      • 9.13.3 Operating business segments

      • 9.13.4 Product portfolio

      • 9.13.5 Business performance

      • 9.13.6 Key strategic moves and developments

    • 9.14 Ningbo David Medical Device Co., Ltd.

      • 9.14.1 Company overview

      • 9.14.2 Company snapshot

      • 9.14.3 Operating business segments

      • 9.14.4 Product portfolio

      • 9.14.5 Business performance

      • 9.14.6 Key strategic moves and developments

    • 9.15 Zhengzhou Dison Instrument And Meter Co., Ltd

      • 9.15.1 Company overview

      • 9.15.2 Company snapshot

      • 9.15.3 Operating business segments

      • 9.15.4 Product portfolio

      • 9.15.5 Business performance

      • 9.15.6 Key strategic moves and developments

    • 9.16 AngioDynamics

      • 9.16.1 Company overview

      • 9.16.2 Company snapshot

      • 9.16.3 Operating business segments

      • 9.16.4 Product portfolio

      • 9.16.5 Business performance

      • 9.16.6 Key strategic moves and developments

    • 9.17 Vygon (UK) Ltd

      • 9.17.1 Company overview

      • 9.17.2 Company snapshot

      • 9.17.3 Operating business segments

      • 9.17.4 Product portfolio

      • 9.17.5 Business performance

      • 9.17.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 2. NEONATAL INTENSIVE CARE MARKET SIZE, FOR WARMERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 3. NEONATAL INTENSIVE CARE MARKET FOR WARMERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 4. NEONATAL INTENSIVE CARE MARKET SIZE, FOR INCUBATORS, BY REGION, 2021-2031 ($MILLION)
    TABLE 5. NEONATAL INTENSIVE CARE MARKET FOR INCUBATORS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 6. GLOBAL INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 7. NEONATAL INTENSIVE CARE MARKET, FOR HYBRID INCUBATOR, BY REGION, 2021-2031 ($MILLION)
    TABLE 8. NEONATAL INTENSIVE CARE MARKET, FOR NORMAL INCUBATOR, BY REGION, 2021-2031 ($MILLION)
    TABLE 9. NEONATAL INTENSIVE CARE MARKET, FOR TRANSPORT INCUBATOR, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. NEONATAL INTENSIVE CARE MARKET SIZE, FOR MONITORING DEVICES, BY REGION, 2021-2031 ($MILLION)
    TABLE 11. NEONATAL INTENSIVE CARE MARKET FOR MONITORING DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 12. NEONATAL INTENSIVE CARE MARKET SIZE, FOR RESPIRATORY DEVICES, BY REGION, 2021-2031 ($MILLION)
    TABLE 13. NEONATAL INTENSIVE CARE MARKET FOR RESPIRATORY DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 14. NEONATAL INTENSIVE CARE MARKET SIZE, FOR PHOTOTHERAPY EQUIPMENT, BY REGION, 2021-2031 ($MILLION)
    TABLE 15. NEONATAL INTENSIVE CARE MARKET FOR PHOTOTHERAPY EQUIPMENT, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 16. NEONATAL INTENSIVE CARE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 17. NEONATAL INTENSIVE CARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 18. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 19. NEONATAL INTENSIVE CARE MARKET SIZE, FOR NEONATAL HYPOTHERMIA & LOW BIRTH WEIGHT, BY REGION, 2021-2031 ($MILLION)
    TABLE 20. NEONATAL INTENSIVE CARE MARKET FOR NEONATAL HYPOTHERMIA & LOW BIRTH WEIGHT, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 21. NEONATAL INTENSIVE CARE MARKET SIZE, FOR JAUNDICE, BY REGION, 2021-2031 ($MILLION)
    TABLE 22. NEONATAL INTENSIVE CARE MARKET FOR JAUNDICE, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 23. NEONATAL INTENSIVE CARE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 24. NEONATAL INTENSIVE CARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 25. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 26. NEONATAL INTENSIVE CARE MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 27. NEONATAL INTENSIVE CARE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 28. NEONATAL INTENSIVE CARE MARKET SIZE, FOR MATERNITY HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 29. NEONATAL INTENSIVE CARE MARKET FOR MATERNITY HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 30. NEONATAL INTENSIVE CARE MARKET SIZE, FOR NEONATAL & PEDIATRIC HOSPITAL, BY REGION, 2021-2031 ($MILLION)
    TABLE 31. NEONATAL INTENSIVE CARE MARKET FOR NEONATAL & PEDIATRIC HOSPITAL, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 32. NEONATAL INTENSIVE CARE MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 33. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 34. NORTH AMERICA INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 35. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 36. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 37. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 38. U.S. NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 39. U.S. NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 40. U.S. NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 41. CANADA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 42. CANADA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 43. CANADA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 44. MEXICO NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 45. MEXICO NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 46. MEXICO NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 47. EUROPE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 48. EUROPE INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 49. EUROPE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 50. EUROPE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 51. EUROPE NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 52. GERMANY NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 53. GERMANY NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 54. GERMANY NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 55. FRANCE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 56. FRANCE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 57. FRANCE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 58. UK NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 59. UK NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 60. UK NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 61. ITALY NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 62. ITALY NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 63. ITALY NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 64. SPAIN NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 65. SPAIN NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 66. SPAIN NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 67. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 68. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 69. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 70. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 71. ASIA-PACIFIC INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 72. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 73. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 74. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 75. CHINA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 76. CHINA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 77. CHINA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 78. JAPAN NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 79. JAPAN NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 80. JAPAN NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 81. INDIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 82. INDIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 83. INDIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 84. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 85. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 86. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 87. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 88. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 89. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 90. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 91. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 92. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 93. LAMEA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 94. LAMEA INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 95. LAMEA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 96. LAMEA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 97. LAMEA NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 98. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 99. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 100. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 101. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 102. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 103. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 104. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 105. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 106. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 107. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 108. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 109. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 110.DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT
    TABLE 111.DRÄGERWERK AG & CO. KGAA: OPERATING SEGMENTS
    TABLE 112.DRÄGERWERK AG & CO. KGAA: PRODUCT PORTFOLIO
    TABLE 113.DRÄGERWERK AG & CO. KGAA: NET SALES,
    TABLE 114.DRÄGERWERK AG & CO. KGAA: KEY STRATERGIES
    TABLE 115.GE COMPANY: COMPANY SNAPSHOT
    TABLE 116.GE COMPANY: OPERATING SEGMENTS
    TABLE 117.GE COMPANY: PRODUCT PORTFOLIO
    TABLE 118.GE COMPANY: NET SALES,
    TABLE 119.GE COMPANY: KEY STRATERGIES
    TABLE 120.MASIMO CORPORATION: COMPANY SNAPSHOT
    TABLE 121.MASIMO CORPORATION: OPERATING SEGMENTS
    TABLE 122.MASIMO CORPORATION: PRODUCT PORTFOLIO
    TABLE 123.MASIMO CORPORATION: NET SALES,
    TABLE 124.MASIMO CORPORATION: KEY STRATERGIES
    TABLE 125.3M COMPANY: COMPANY SNAPSHOT
    TABLE 126.3M COMPANY: OPERATING SEGMENTS
    TABLE 127.3M COMPANY: PRODUCT PORTFOLIO
    TABLE 128.3M COMPANY: NET SALES,
    TABLE 129.3M COMPANY: KEY STRATERGIES
    TABLE 130.PHOENIX MEDICAL SYSTEMS PVT LTD.: COMPANY SNAPSHOT
    TABLE 131.PHOENIX MEDICAL SYSTEMS PVT LTD.: OPERATING SEGMENTS
    TABLE 132.PHOENIX MEDICAL SYSTEMS PVT LTD.: PRODUCT PORTFOLIO
    TABLE 133.PHOENIX MEDICAL SYSTEMS PVT LTD.: NET SALES,
    TABLE 134.PHOENIX MEDICAL SYSTEMS PVT LTD.: KEY STRATERGIES
    TABLE 135.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 136.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 137.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 138.MEDTRONIC PLC: NET SALES,
    TABLE 139.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 140.KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
    TABLE 141.KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
    TABLE 142.KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
    TABLE 143.KONINKLIJKE PHILIPS N.V: NET SALES,
    TABLE 144.KONINKLIJKE PHILIPS N.V: KEY STRATERGIES
    TABLE 145.FANEM MEDICAL DEVICES: COMPANY SNAPSHOT
    TABLE 146.FANEM MEDICAL DEVICES: OPERATING SEGMENTS
    TABLE 147.FANEM MEDICAL DEVICES: PRODUCT PORTFOLIO
    TABLE 148.FANEM MEDICAL DEVICES: NET SALES,
    TABLE 149.FANEM MEDICAL DEVICES: KEY STRATERGIES
    TABLE 150.ATOM MEDICA: COMPANY SNAPSHOT
    TABLE 151.ATOM MEDICA: OPERATING SEGMENTS
    TABLE 152.ATOM MEDICA: PRODUCT PORTFOLIO
    TABLE 153.ATOM MEDICA: NET SALES,
    TABLE 154.ATOM MEDICA: KEY STRATERGIES
    TABLE 155.MEDIPREMA GROUP: COMPANY SNAPSHOT
    TABLE 156.MEDIPREMA GROUP: OPERATING SEGMENTS
    TABLE 157.MEDIPREMA GROUP: PRODUCT PORTFOLIO
    TABLE 158.MEDIPREMA GROUP: NET SALES,
    TABLE 159.MEDIPREMA GROUP: KEY STRATERGIES
    TABLE 160.SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT
    TABLE 161.SIEMENS HEALTHCARE GMBH: OPERATING SEGMENTS
    TABLE 162.SIEMENS HEALTHCARE GMBH: PRODUCT PORTFOLIO
    TABLE 163.SIEMENS HEALTHCARE GMBH: NET SALES,
    TABLE 164.SIEMENS HEALTHCARE GMBH: KEY STRATERGIES
    TABLE 165.TERUMO CORPORATION: COMPANY SNAPSHOT
    TABLE 166.TERUMO CORPORATION: OPERATING SEGMENTS
    TABLE 167.TERUMO CORPORATION: PRODUCT PORTFOLIO
    TABLE 168.TERUMO CORPORATION: NET SALES,
    TABLE 169.TERUMO CORPORATION: KEY STRATERGIES
    TABLE 170.MEDICOR ELEKTRONIKA: COMPANY SNAPSHOT
    TABLE 171.MEDICOR ELEKTRONIKA: OPERATING SEGMENTS
    TABLE 172.MEDICOR ELEKTRONIKA: PRODUCT PORTFOLIO
    TABLE 173.MEDICOR ELEKTRONIKA: NET SALES,
    TABLE 174.MEDICOR ELEKTRONIKA: KEY STRATERGIES
    TABLE 175.NINGBO DAVID MEDICAL DEVICE CO., LTD.: COMPANY SNAPSHOT
    TABLE 176.NINGBO DAVID MEDICAL DEVICE CO., LTD.: OPERATING SEGMENTS
    TABLE 177.NINGBO DAVID MEDICAL DEVICE CO., LTD.: PRODUCT PORTFOLIO
    TABLE 178.NINGBO DAVID MEDICAL DEVICE CO., LTD.: NET SALES,
    TABLE 179.NINGBO DAVID MEDICAL DEVICE CO., LTD.: KEY STRATERGIES
    TABLE 180.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: COMPANY SNAPSHOT
    TABLE 181.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: OPERATING SEGMENTS
    TABLE 182.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: PRODUCT PORTFOLIO
    TABLE 183.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: NET SALES,
    TABLE 184.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: KEY STRATERGIES
    TABLE 185.ANGIODYNAMICS: COMPANY SNAPSHOT
    TABLE 186.ANGIODYNAMICS: OPERATING SEGMENTS
    TABLE 187.ANGIODYNAMICS: PRODUCT PORTFOLIO
    TABLE 188.ANGIODYNAMICS: NET SALES,
    TABLE 189.ANGIODYNAMICS: KEY STRATERGIES
    TABLE 190.VYGON (UK) LTD: COMPANY SNAPSHOT
    TABLE 191.VYGON (UK) LTD: OPERATING SEGMENTS
    TABLE 192.VYGON (UK) LTD: PRODUCT PORTFOLIO
    TABLE 193.VYGON (UK) LTD: NET SALES,
    TABLE 194.VYGON (UK) LTD: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.NEONATAL INTENSIVE CARE MARKET SEGMENTATION
    FIGURE 2.NEONATAL INTENSIVE CARE MARKET,2021-2031
    FIGURE 3.NEONATAL INTENSIVE CARE MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.NEONATAL INTENSIVE CARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.NEONATAL INTENSIVE CARE MARKET,BY PRODUCT,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF WARMERS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INCUBATORS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF MONITORING DEVICES NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF RESPIRATORY DEVICES NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PHOTOTHERAPY EQUIPMENT NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 19.NEONATAL INTENSIVE CARE MARKET,BY APPLICATION,2021(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF NEONATAL HYPOTHERMIA & LOW BIRTH WEIGHT NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF JAUNDICE NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHERS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 23.NEONATAL INTENSIVE CARE MARKET,BY END USER,2021(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOSPITALS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 25.COMPARATIVE SHARE ANALYSIS OF MATERNITY HOSPITALS NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 26.COMPARATIVE SHARE ANALYSIS OF NEONATAL & PEDIATRIC HOSPITAL NEONATAL INTENSIVE CARE MARKET,2021-2031(%)
    FIGURE 27.NEONATAL INTENSIVE CARE MARKET BY REGION,2021
    FIGURE 28.U.S. NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 29.CANADA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 30.MEXICO NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 31.GERMANY NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 32.FRANCE NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 33.UK NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 34.ITALY NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 35.SPAIN NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 36.REST OF EUROPE NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 37.CHINA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 38.JAPAN NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 39.INDIA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 40.AUSTRALIA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 41.SOUTH KOREA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 42.REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 43.BRAZIL NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 44.SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 45.SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 46.REST OF LAMEA NEONATAL INTENSIVE CARE MARKET,2021-2031($MILLION)
    FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 51.COMPETITIVE DASHBOARD
    FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 53.DRÄGERWERK AG & CO. KGAA.: NET SALES ,($MILLION)
    FIGURE 54.GE COMPANY.: NET SALES ,($MILLION)
    FIGURE 55.MASIMO CORPORATION.: NET SALES ,($MILLION)
    FIGURE 56.3M COMPANY.: NET SALES ,($MILLION)
    FIGURE 57.PHOENIX MEDICAL SYSTEMS PVT LTD..: NET SALES ,($MILLION)
    FIGURE 58.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 59.KONINKLIJKE PHILIPS N.V.: NET SALES ,($MILLION)
    FIGURE 60.FANEM MEDICAL DEVICES.: NET SALES ,($MILLION)
    FIGURE 61.ATOM MEDICA.: NET SALES ,($MILLION)
    FIGURE 62.MEDIPREMA GROUP.: NET SALES ,($MILLION)
    FIGURE 63.SIEMENS HEALTHCARE GMBH.: NET SALES ,($MILLION)
    FIGURE 64.TERUMO CORPORATION.: NET SALES ,($MILLION)
    FIGURE 65.MEDICOR ELEKTRONIKA.: NET SALES ,($MILLION)
    FIGURE 66.NINGBO DAVID MEDICAL DEVICE CO., LTD..: NET SALES ,($MILLION)
    FIGURE 67.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD.: NET SALES ,($MILLION)
    FIGURE 68.ANGIODYNAMICS.: NET SALES ,($MILLION)
    FIGURE 69.VYGON (UK) LTD.: NET SALES ,($MILLION)

Purchase Full Report of
Neonatal Intensive Care Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue